Alkermes

Yahoo Finance • 2 days ago

Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid

[M&A Mergers And Acquisitions] narvo vexar Alkermes (ALKS [https://seekingalpha.com/symbol/ALKS]) has raised its buyout offer for Avadel Pharmaceuticals (AVDL [https://seekingalpha.com/symbol/AVDL]), indicating a price of up to $22.50 per... Full story

Yahoo Finance • 2 days ago

Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION DUBLIN, Nov. 19, 2025 /PRNewswire/ -... Full story

Yahoo Finance • 4 days ago

Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOU... Full story

Yahoo Finance • 5 days ago

Avadel (AVDL) Gets 26% Boost on Takeover Bid

We recently published 10 Market Movers That Made Millionaires in a Week. Avadel Pharmaceuticals plc (NASDAQ:AVDL) is one of the best-performing stocks of the past trading week. Avadel jumped by 26.06 percent week-on-week as investors load... Full story

Yahoo Finance • 6 days ago

Can Alkermes (ALKS) Overcome Modest Differentiation to Lead in Narcolepsy Treatment Innovation?

Alkermes recently reported positive topline results from its Vibrance-2 phase 2 study of alixorexton in patients with narcolepsy type 2, with the therapy meeting both primary efficacy endpoints and showing a generally well-tolerated safety... Full story

Yahoo Finance • 6 days ago

Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War

We recently published Lackluster Market? Not for These 10 Soaring Stocks. Avadel Pharmaceuticals plc (NASDAQ:AVDL) is one of the best-performing stocks on Friday. Avadel extended its winning streak to a 5th straight day on Friday to hit a... Full story

Yahoo Finance • 7 days ago

Avadel Receives Unsolicited Proposal from Lundbeck

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOU... Full story

Yahoo Finance • 9 days ago

Stocks making the biggest moves midday: Goldman Sachs, AMD, Oklo, Circle Internet & more

Check out the companies making the biggest moves midday: Alkermes — The biotech company dropped 9% as traders weighed phase 2 trial results for its ALKS 2680 drug, which aims to treat narcolepsy. While the company will be advancing the dru... Full story

Yahoo Finance • 9 days ago

DraftKings downgraded, Instacart upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI A... Full story

Yahoo Finance • 24 days ago

Alkermes plc Reports Third Quarter 2025 Financial Results

— Third Quarter Revenues of $394.2 Million — — GAAP Net Income of $82.8 Million and Diluted GAAP Earnings per Share of $0.49 — — Company Raises 2025 Financial Expectations — DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: AL... Full story

Yahoo Finance • 25 days ago

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * PayPal Holdings (PYPL [https://seekingalpha.com/symbol/PYPL]) * UnitedHealth Group Incorporated (UNH [https://seekingalpha.com/symbol/UNH]) * Ares Capital Corporation (AR... Full story

Yahoo Finance • 30 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA)

BALA CYNWYD, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

Deutsche Bank’s ‘Conviction list’ for Q4: KO, SCHW, LLY and more

[Journey of Distinction - Gradient Spheres Tapering Along Steps to a Singular Summit] J Studios/DigitalVision via Getty Images Deutsche Bank’s research team selected their top investment ideas to hold over the next 12 months, with new pic... Full story

Yahoo Finance • 2 months ago

Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says

Alkermes' (ALKS) 7% stock decline following results of its phase 2 study of alixorexton in patients PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Alkermes upgraded at RBC Capital Markets ahead of key catalyst

[Wall Street New York stock exchange stock market] alexsl Alkermes (NASDAQ:ALKS [https://seekingalpha.com/symbol/ALKS]) shares spiked on Friday after RBC Capital Markets upgraded the Irish biotech to Outperform from Sector Perform, citing... Full story

Yahoo Finance • 2 months ago

CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Rothschild & Co Redburn upgraded Kenvue... Full story

Yahoo Finance • 2 months ago

HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study

Alkermes (NASDAQ:ALKS) is one of the best beginner stocks to buy, according to analysts. On September 9, HC Wainwright reiterated a ‘Neutral’ rating on the stock and a $46 price target. The stance follows the company’s positive results fro... Full story

Yahoo Finance • 2 months ago

Alkermes appoints new CFO

* Joshua Reed has been appointed as chief financial officer of Alkermes (NASDAQ:ALKS [https://seekingalpha.com/symbol/ALKS]), effective September 15, 2025. * Reed previously served as CFO of Omega Therapeutics and Aldeyra Therapeutics... Full story

Yahoo Finance • 2 months ago

Notable Monday Option Activity: ALKS, BBWI, CVS

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (Symbol: ALKS), where a total of 8,976 contracts have traded so far, representing approximately 897,600 underlying sh... Full story

Yahoo Finance • 4 months ago

ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics

ALKERMES PLC (NASDAQ:ALKS [https://www.chartmill.com/stock/quote/ALKS]) has been recognized as a possible choice for value investors using a "Decent Value" screening method. This approach targets stocks with solid fundamental valuations, s... Full story